When mean pre-baseline healthcare costs are compared with post-baseline costs, there is a nonsignificant trend for tested patients to have a higher mean cost ($5,010, median −$2,167, range −$95 051 to $157 716) than non-tested patients (−$6,693, median −$9,511, range −$108 290 to $210 716; P =0.08).
← all excerpts
Pharmacogenomic testing and outcome among depressed patients in a tertiary care outpatient psychiatric consultation practice.
1
—
—